Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC)
Part of paid clinical trials in Jacksonville, Florida.
- Sponsor
- Coologics, Inc
- Study ID
- NCT06983041
- Status
- Recruiting
Conditions
- Vulvovaginal Candidiasis (VVC)
- Yeast Vaginitis
Eligibility Criteria
- Sex
- FEMALE
- Age
- 22 Years - 49 Years
- Healthy Volunteers
- Not accepted
Interventions
- vaginal cooling device — DEVICEmedical grade polymer capsule filled with inert fluid (15 cc's)
Study Details
The objective of this study is to determine clinical cure rate and safety of a proprietary Vaginal Cooling Device (VCD) in women with VCC. In addition, the safety, mycological cure rates, the speed and efficacy of symptom resolution, vaginal hyphae and polymorphonuclear (PMN) scores, and Quality-of-Life (QoL) parameters will be determined.
Key Dates
- Start date
- May 22, 2025
- Status verified
- Jan 2026
- Primary completion
- Jun 30, 2026
- Completion
- Jun 30, 2026
Study Design
- Enrollment
- 55 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Other: uncomplicated vulvovaginal candidiasisTwice daily use of vaginal cooling device for 30 minutes a time for three days (i.e., 3 hours total) in female subjects with VVC age 22-49 (inclusive).
Primary Outcome Measure
Number of clinical cures at 7 days [ Time Frame: 7 days (+/-2) ]
Central Contacts
- Kimberly J Langdon, MD740-206-4287
- Keith Aqua, MD561-951-8212
Locations (10)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Symphony Clinical Research | Jacksonville | Florida | 32224 | Nancy Slay Daniel McDyer, MD (PRINCIPAL_INVESTIGATOR) |
| Nova Clinical Research | Miami | Florida | 33162 | Christ-Ann Maglorie, MD (PRINCIPAL_INVESTIGATOR) |
| Pivotal Clinical Research & Associates | Smyrna | Georgia | 30082 | Melinda Miller-Thrasher, MD (PRINCIPAL_INVESTIGATOR) |
| Renew Health Clinical Research | Snellville | Georgia | 30078 | Pharonda Lee Tyndal Jones, MD (PRINCIPAL_INVESTIGATOR) |
| Leavitt Clinical Research | Idaho Falls | Idaho | 83404 | - |
| Next Innovative Clinical Research | Chicago | Illinois | 60616 | Imani Gardner Monica Moore, MD (PRINCIPAL_INVESTIGATOR) |
| Unified Women's Clinical Research-Raleigh | Raleigh | North Carolina | 27607 | Ann Collins, MD (PRINCIPAL_INVESTIGATOR) |
| Lyndhurst Clinical Research | Winston-Salem | North Carolina | 27103 | Robert Parker, MD (PRINCIPAL_INVESTIGATOR) |
| Aviati Health | Memphis | Tennessee | 38115 | - |
| Vilo Research Group, Inc. | Houston | Texas | 77070 | Tamara Sanchez Elvis Massip Perez, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Jacksonville, FL
Related Studies
- Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal CandidiasisPHASE3 · Recruiting · pH-D Feminine Health LLC · Mobile, Alabama